Esperion Therapeutics Inc (NAS:ESPR)
$ 2.29 0.12 (5.53%) Market Cap: 433.86 Mil Enterprise Value: 453.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Esperion Therapeutics Inc at Stifel Virtual Healthcare Conference Transcript

Nov 17, 2020 / 01:40PM GMT
Release Date Price: $30.13 (+0.17%)
Derek Christian Archila
Stifel, Nicolaus & Company, Incorporated, Research Division - Director & Senior Analyst

All right. Good morning, everyone, and welcome to day 2 of the Stifel Healthcare Conference. I'm Derek Archila, one of the senior biotech analyst here at Stifel. I'm pleased to be joined by our next presenter, Esperion Therapeutics. From the company, we have CEO, Tim Mayleben, to the left there; and then we have Rick Bartram, CFO, to the right there. Gentlemen, thank you so much for joining us.

Timothy M. Mayleben
Esperion Therapeutics, Inc. - President, CEO & Director

Good morning, Derek. Thanks for having us. Look forward to the discussion.

Derek Christian Archila;Timothy M. Mayleben
Stifel, Nicolaus & Company, Incorporated, Research Division - Director & Senior Analyst;Esperion

All right. Well, maybe just to start. Maybe, Tim, do you want to just do a brief intro of what you guys have been up to and then we can kind of dig into the Q&A here?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot